Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Academic Article

Publication Date:

2022

Iris type:

1.1.4. Guidelines, Consensus

Keywords:

antibody drug conjugates; bladder cancer; fibroblast growth factor receptor inhibitors; immune checkpoint inhibitors; platinum-based chemotherapy; urothelial carcinoma; Follow-Up Studies; Humans; Carcinoma, Transitional Cell; Immunoconjugates; Urinary Bladder Neoplasms

List of contributors:

Powles, T; Bellmunt, J; Comperat, E; De Santis, M; Huddart, R; Loriot, Y; Necchi, A; Valderrama, B P; Ravaud, A; Shariat, S F; Szabados, B; van der Heijden, M S; Gillessen, S

Authors of the University:

NECCHI ANDREA

Handle:

https://iris.unisr.it/handle/20.500.11768/132682

Published in:

ANNALS OF ONCOLOGY

Journal